OM Pharma

OM Pharma is a Swiss biopharmaceutical company working on immune health through bacterial lysates - innovative medicines designed to prime and strengthen the immune system to prevent infections. The company also develops microbial-derived immunotherapeutic products aimed at acute and chronic immunological disorders. Its technical work spans immunology, microbial-derived immunotherapeutics, biopharmaceutical manufacturing and research and development, with end-to-end manufacturing carried out in full compliance with Good Manufacturing Practice (GMP) standards.

The company is headquartered on a biotech campus with state-of-the-art facilities in Geneva, Switzerland, and has a company history spanning nearly a century. It reports investing heavily in research and development.

OM Pharma describes its working environment as agile and cross-functional, with an emphasis on entrepreneurial spirit, freedom to take initiative, and real ownership of projects. The company frames its culture around bringing different perspectives together to address complex health challenges.